1e
19
1
49
2
2
18
1b
1d
18
34
57
1d
2 29
1d
25
Yu-Xiao Yang, MD, MSCE
78
57
Associate Professor of Medicine (Gastroenterology)
28
73
3
5f
Attending Physician, Penn Presbyterian Medical Center (PPMC)
7c
Attending Physician, Hospital of the University of Pennsylvania (HUP)
72
Attending Physician, Veterans Affairs Medical Center (VAMC)
8a
Senior Scholar, Center for Epidemiology & Biostatistics, University of Pennsylvania
7b
Co-Director, Gastroenterology and Hepatology Research Program, UPENN
11
Department: Medicine
4
1
b
1d
46
Contact information
60
4
3
3
1d
60
Center for Clinical Epidemiology and Biostatistics
1b 423 Guardian Drive
34 733 Blockley Hall
Philadelphia, PA 19104
26
1b 423 Guardian Drive
34 733 Blockley Hall
Philadelphia, PA 19104
2e
Office: 215-573-5027
30
91
30
Email:
yangy@mail.med.upenn.edu
12
yangy@mail.med.upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
ca Search PubMed for articles
b3 University of Pennsylvania Perelman School of Medicine Center for Clinical Epidemiology and Biostatistics
e9 Penn Medicine Esophageal and Swallowing Disorders Program
c
4
b
1f
ca Search PubMed for articles
b3 University of Pennsylvania Perelman School of Medicine Center for Clinical Epidemiology and Biostatistics
e9 Penn Medicine Esophageal and Swallowing Disorders Program
c
13
Education:
21 7 BE 23 (Electrical Engineering) c
31 City College of New York, 1992.
21 7 MD c
3f New York University School of Medicine, 1996.
21 9 MSCE c
33 University of Pennsylvania, 2003.
c
3
3
3
3
8b
Permanent link21 7 BE 23 (Electrical Engineering) c
31 City College of New York, 1992.
21 7 MD c
3f New York University School of Medicine, 1996.
21 9 MSCE c
33 University of Pennsylvania, 2003.
c
2 29
21
1e
1d
24
2b
29
27
23
188 Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM.: GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 184(1): 1314-1323, Nov 2024.
13f Brown TJ, Gimotty PA, Mamtani R, Karasic TB, Yang YX.: Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO Clin Cancer Inform 8: e2300220, Aug 2024.
137 Tobi M, Pascua M, Rodriguez R, Yang YX, Lieb J, Weinstein D, Kaplan DE: Prospective Visual Inspection of the Ventrum of Tongue (VIVOT) Vasculature Predicts the Presence of Esophageal Varices. Gastrointest Disord 6(1): 230-240, Feb 2024.
125 Wang L, Rahimi Larki N, Dobkin J, Salgado S, Ahmad N, Kaplan DE, Yang W, Yang YX.: A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis. Pancreas 53(3): e254-e259, 2024.
11f Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX.: Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. Am J Gastroenterology 2024 Notes: In press.
116 Lam R, Hwang WT, Chennareddy S, Boursi B, Yang YX: Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Dig Dis Sci 2024 Notes: In Press.
148 Mezzacappa C, Larki NR, Skanderson M, Park LS, Brandt C, Hauser RG, Justice A, Yang YX, Wang L.: Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration. Dig Dis Sci 69(4): 1507-1513, 2024.
194 Kurlander JE, Laine L, Kim HM, Roberts CB, Saffar D, Myers A, Holleman R, Gao Y, Shank M, Nelson R, Forman J, Helfrich CD, Krein SL, Saini SD, Yang YX: Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study. BMJ 385: e076484, 2024.
12f Wang L, Grimshaw AA, Mezzacappa C, Rahimi Larki N, Yang YX, Justice AC: Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Cancer Epidemiol Biomarkers Prev August 2023 Notes: In press.
2c
7
1d
1f
Selected Publications
d9 Khan AN, Jones RB Jr, Khan N, Yang YX, Adler RA.: Trends in hip fracture rates in US male veterans. Osteoporos Int. 35(12): 2137-2144, Dec 2024.188 Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM.: GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 184(1): 1314-1323, Nov 2024.
13f Brown TJ, Gimotty PA, Mamtani R, Karasic TB, Yang YX.: Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO Clin Cancer Inform 8: e2300220, Aug 2024.
137 Tobi M, Pascua M, Rodriguez R, Yang YX, Lieb J, Weinstein D, Kaplan DE: Prospective Visual Inspection of the Ventrum of Tongue (VIVOT) Vasculature Predicts the Presence of Esophageal Varices. Gastrointest Disord 6(1): 230-240, Feb 2024.
125 Wang L, Rahimi Larki N, Dobkin J, Salgado S, Ahmad N, Kaplan DE, Yang W, Yang YX.: A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis. Pancreas 53(3): e254-e259, 2024.
11f Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX.: Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. Am J Gastroenterology 2024 Notes: In press.
116 Lam R, Hwang WT, Chennareddy S, Boursi B, Yang YX: Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Dig Dis Sci 2024 Notes: In Press.
148 Mezzacappa C, Larki NR, Skanderson M, Park LS, Brandt C, Hauser RG, Justice A, Yang YX, Wang L.: Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration. Dig Dis Sci 69(4): 1507-1513, 2024.
194 Kurlander JE, Laine L, Kim HM, Roberts CB, Saffar D, Myers A, Holleman R, Gao Y, Shank M, Nelson R, Forman J, Helfrich CD, Krein SL, Saini SD, Yang YX: Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study. BMJ 385: e076484, 2024.
12f Wang L, Grimshaw AA, Mezzacappa C, Rahimi Larki N, Yang YX, Justice AC: Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Cancer Epidemiol Biomarkers Prev August 2023 Notes: In press.
2c